Recent literature reports state that the screening is only recommended for the high-risk population identified as those with a family history of the disease, women with BRCA1 and BRCA2 mutations, or with hereditary nonpolyposis colorectal cancer. Here, BRCA2 is linked to hereditary nonpolyposis colon cancer.